When the tumor size reached at palpable size, the three groups of mice were subcutaneously treated with pLV-GEP-WT1, pLL3.7-WT1-shRNA (plasmid expressing WT1-shRNA) with wild type WT1 and empty plasmid (as a control). The gene discussed is WT1; the disease is neoplasm.